GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.24	GSK Reports Headline Results From FIRST-ENGOT-OV44 Phase III Trial - Quick Facts (RTTNews)
09.12.24	GSK: FDA Accepts For Review Submission For New Indication Of Nucala In COPD (RTTNews)
05.12.24	GSK, Zhifei Revise And Extend Strategic Vaccine Collaboration In China (RTTNews)
25.11.24	GSK :FDA Accepts Blenrep Combination For Review In Treatment Of Relapsed/Refractory Multiple Myeloma (RTTNews)
22.11.24	GSK Plc Announces Regulatory Expansion For Arexvy In Japan To Include Adults Aged 50-59 (RTTNews)
14.11.24	GSK Reports Positive Headline Results From DREAMM-7 Phase III Trial (RTTNews)
30.10.24	GSK Q3 Results Down, Sees FY24 Outlook At Mid Range; Stock Drops (RTTNews)
30.10.24	GSK Q3 Pre-tax Profit Drops; Confirms 2024 Outlook - Quick Facts (RTTNews)
16.10.24	GSK Plc: NDA For Gepotidacin Granted Priority Review By FDA - Quick Facts (RTTNews)
10.10.24	GSK Reaches $2.2 Bln Settlement Over Zantac Liability Cases (RTTNews)
08.10.24	GSK Announces Positive Data From AReSVi-006 Phase III Trial For RSV Vaccine Arexvy (RTTNews)
24.09.24	GSK: CHMP Issues Positive Opinion On New Fully Liquid Presentation Of Menveo Meningococcal Vaccine (RTTNews)
18.09.24	GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines (RTTNews)
18.09.24	GSK Settles 2 Cases In California Against Zantac (RTTNews)
17.09.24	GSK: Japan Accepts For Review NDA For Blenrep Combinations In Relapsed/refractory Multiple Myeloma (RTTNews)
13.09.24	GSK : Blenrep Combination Receives Breakthrough Therapy Designation For Multiple Myeloma In China (RTTNews)
12.09.24	GSK Announces Promising Data From Phase II Seasonal Influenza MRNA Vaccine Program (RTTNews)
06.09.24	GSK : Phase III Trial Of Nucala In Chronic Obstructive Pulmonary Disease Meets Primary Endpoint (RTTNews)
28.08.24	GSK Welcomes Delaware Supreme Court's Review Of Expert Evidence Ruling (RTTNews)
28.08.24	GSK: Japanese Ministry Of Health, Labour And Welfare Grants SENKU Designation For Bepirovirsen (RTTNews)
28.08.24	Japan Approves GSK's Nucala For Treating Adults With Chronic Rhinosinusitis With Nasal Polyps (RTTNews)
20.08.24	GSK :GSK5764227 Gets FDA Breakthrough Therapy Designation For Extensive-stage Small-cell Lung Cancer (RTTNews)
16.08.24	GSK To Seek Dismissal Of Wilson Case In Florida After Favorable Daubert Ruling (RTTNews)
02.08.24	GSK Reports Expanded Approval For Jemperli Plus Chemotherapy (RTTNews)
31.07.24	ViiV Healthcare Reports Positive Data For 2-Drug Regimen DOVATO In HIV-1 Treatment (RTTNews)
31.07.24	GSK Q2 Profit Declines, Sales Rise; Lifts FY24 Guidance; Declares Dividend (RTTNews)
29.07.24	GSK Reaches Confidential Settlement With Ronald Kimbrow Involving Ranitidine (RTTNews)
29.07.24	Biotech Stocks Facing FDA Decision In August 2024 (RTTNews)
29.07.24	GSK's RSV Vaccine Arexvy Gets Positive CHMP Opinion For Adults Aged 50-59 At Increased Risk (RTTNews)
23.07.24	SCYNEXIS To Receive $10 Mln Milestone Payment From GSK For Completed Clinical Study Report (RTTNews)
11.07.24	GSK Plans To Distribute Over 36 Mln Doses Of Trivalent Influenza Vaccines In The US (RTTNews)
03.07.24	GSK Acquires Global Rights For MRNA Vaccines For Influenza & COVID-19 In CureVac Deal - Quick Facts (RTTNews)
10.06.24	GSK's Arexvy RSV Vaccine Gets FDA's Approval For Adults Aged 50-59 (RTTNews)
03.06.24	GSK Plc: Jemperli Trial Shows Unprecedented Results (RTTNews)
03.06.24	GSK: DREAMM-8 Phase III Trial Shows Positive Results In Relapsed/refractory Multiple Myeloma (RTTNews)
03.06.24	GSK To Appeal Delaware State Court Ruling On Zantac Litigation (RTTNews)
24.05.24	GSK: Court Finds In GSK's Favour In First Zantac Case To Go To Trial (RTTNews)
01.05.24	GSK Q1 Pretax Profit Declines; Updates 2024 Guidance (RTTNews)
24.04.24	GSK : Jemperli Granted Priority Review By FDA For Expanded Use In Endometrial Cancer Treatment (RTTNews)
17.04.24	GSK: Phase III Data Shows Gepotidacin Potential For Uncomplicated Urogenital Gonorrhea Treatment (RTTNews)
16.04.24	FDA Accepts GSK's 5-in-1 Meningococcal ABCWY Vaccine Candidate For Regulatory Review (RTTNews)
21.03.24	Sosei Regains Full Ownership From GSK Of Clinic-Ready GPR35 Agonist For Inflammatory Bowel Disease (RTTNews)
06.03.24	WHO Report Reveals Increased Resistance To HIV Drug Dolutegravir (RTTNews)
29.02.24	GSK Confirms Confidential Settlement With Boyd/Steenvoord (RTTNews)
26.02.24	GSK: Gepotidacin EAGLE-1 Phase III Trial In GC Reports Positive Headline Results (RTTNews)
21.02.24	ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load Suppression : Interim Trial Analysis (RTTNews)
15.02.24	GSK Plc Completes Acquisition Of Aiolos Bio (RTTNews)
31.01.24	GSK Q4 Profit Down, Revenues Rise; Lifts Dividend; Sees Growth In FY24 (RTTNews)
10.01.24	GSK : Nucala Approved In China For Severe Asthma Treatment With Eosinophilic Phenotype (RTTNews)
20.12.23	GSK Inks License Deal With China's Hansoh Pharma For HS-20093; To Pay Up To $1.7 Bln (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft